Application | Comment | Organism |
---|---|---|
medicine | IKK2 inhibition represents a promising strategy for the treatment of advanced stages of cutaneous T-cell lymphomas | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | a vector expressing a mutant form of IKK2 is used, characterized by the substitution of two serine residues with alanines, leading to inhibition of IKK2 autophosphorylation required for IKK activity | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
AS602868 | - |
Homo sapiens | |
N-(3,5-bis-trifluoromethylphenyl)-5-chloro-2-hydroxybenzamide | - |
Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [IkappaB protein] | Homo sapiens | - |
ADP + [IkappaB phosphoprotein] | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HUT-78 cell | - |
Homo sapiens | - |
JURKAT cell | - |
Homo sapiens | - |
MyLa 2059 cell | mycosis fungoides cell line | Homo sapiens | - |
SeAx cell | - |
Homo sapiens | - |
T-cell lymphoma cell | cutaneous T-cell lymphoma | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [IkappaB protein] | - |
Homo sapiens | ADP + [IkappaB phosphoprotein] | - |
? |
Subunits | Comment | Organism |
---|---|---|
heterotrimer | IkappaB kinase, IKK, is composed of two catalytic subunits, IKK1 or IKKalpha and IKK2 or IKKbeta, and a regulatory subunit called NEMO or IKKgamma | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
IkappaB kinase | - |
Homo sapiens |
IKK | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens |